I joined Marjanka Schmidt's group in September 2026 as a PhD student within the Hereditary and Early onset breast cancer: Comprehensive personalized Assessment, early Risk Evaluation, and clinical management (HER-CARE) doctoral training programme. I focus on improving contralateral breast cancer risk prediction by integrating genetics, treatment and risk modifiers into statistical models. This will contribute to the creation of a decision-support tool to help clinicians assess this risk.
